This signal integration function of GNB2 is supported by prior studies in breast cancer, where it was shown to be a direct target of miR-142-3p; GNB2 knockdown activated AKT/mTOR signaling, altered autophagic flux, and modulated chemotherapeutic sensitivity [53]. Here, MTOR is linked to breast carcinoma.